Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study

Human Immunology

Volumn 70, Issue 8, 2009, Pages 627-630

  Opelz, Gerhard ^a   Döhler, Bernd ^a   Süsal, Caner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Crossmatch; Graft outcome; Heart transplantation; Kidney transplantation; Liver transplantation

Indexed keywords

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT SURVIVAL; HEART TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOCYTOTOXICITY; ORGAN DONOR; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; T LYMPHOCYTE;

B-LYMPHOCYTES; CADAVER; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; PROGNOSIS; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES; TISSUE DONORS;

EID: 68049137632     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.04.009     Document Type: Article

References (23)

1. Patel R., and Terasaki P.I. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280 (1969) 735-739
2. Bingaman A.W., Murphey C.L., Palma-Vargas J., and Wright F. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation. Transplantation 86 (2008) 1864-1868
3. Collaborative Transplant Study. http://www.ctstransplant.org Accessed March 2009
4. Ettenger R.B., Uittenbogaart C.H., Pennisi A.J., Malekzadeh M.H., and Fine R.N. Long-term cadaver allograft survival in the recipient with a positive B lymphocyte crossmatch. Transplantation 27 (1979) 315-318
5. Hourmant M., Bignon J.D., Cesbron A., and Soulillou J.P. Effect of positive crossmatch against donor B lymphocytes in kidney transplantation: A prospective one-center study. Clin Transpl (1990) 301-309
6. Bryan C.F., Wakefield M., Reese J.C., Shield III C.F., Warady B.A., Winklhofer F.T., et al. Renal graft survival is not influenced by a positive flow B-cell crossmatch. Clin Transplant 21 (2007) 72-79
7. Magee C.C., Felgueiras J., Tinckam K., Malek S., Mah H., and Tullius S. Renal transplantation in patients with positive lymphocytotoxicity crossmatches: One center's experience. Transplantation 86 (2008) 96-103
8. Mahoney R.J., Ault K.A., Given S.R., Adams R.J., Breggia A.C., Paris P.A., et al. The flow-cytometric crossmatch and early renal transplant loss. Transplantation 49 (1990) 527-535
9. Kerman R.H., Van Buren C.T., Lewis R.M., DeVera V., Baghdahsarian V., Gerolami K., et al. Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients. Transplantation 49 (1990) 52-56
10. Cook D.J., Fettouh H.I., Gjertson D.W., and Cecka J.M. Flow cytometry crossmatching (FCXM) in the UNOS Kidney Transplant Registry. Clin Transpl (1998) 413-419
11. Karpinski M., Rush D., Jeffery J., Exner M., Regele H., Dancea S., et al. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol 12 (2001) 2807-2814
12. Bray R.A., Lebeck L.K., and Gebel H.M. The flow-cytometric crossmatch. Dual-color analysis of T-cell and B-cell reactivities. Transplantation 48 (1989) 834-838
13. Opelz G., and Collaborative Transplant Study. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 365 (2005) 1570-1576
14. Mahoney R.J., Taranto S., and Edwards E. B-cell crossmatching and kidney allograft outcome in 9031 United States transplant recipients. Hum Immunol 63 (2002) 324-335
15. Eng H.S., Bennett G., Tsiopelas E., Lake M., Humphreys I., Chang S.H., et al. Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss. Am J Transplant 8 (2008) 2335-2342
16. Christiaans M.H., Overhof R., ten Haaft A., Nieman F., van Hooff J.P., and van den Berg-Loonen E.M. No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients. Transplantation 62 (1996) 1341-1347
17. Smith J.D., Danskine A.J., Laylor R.M., Rose M.L., and Yacoub M.H. The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation. Transpl Immunol 11 (1993) 60-65
18. Bishay E.S., Cook D.J., Starling R.C., Ratliff Jr. N.B., White J., Blackstone E.H., et al. The clinical significance of flow cytometry crossmatching in heart transplantation. Eur J Cardiothorac Surg 174 (2000) 362-369
19. Doyle H.R., Marino I.R., Morelli F., Doria C., Aldrighetti L., McMichael J., et al. Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. Ann Surg 224 (1996) 168-177
20. Hathaway M., Gunson B.K., Keogh A.C., Briggs D., McMaster P., and Neuberger J.M. A positive crossmatch in liver transplantation-no effect or inappropriate analysis?. A prospective study. Transplantation 641 (1997) 54-59
21. Swinnen L.J., Costanzo-Nordin M.R., Fisher S.G., O'Sullivan E.J., Johnson M.R., Heroux A.L., et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 323 (1990) 1723-1728
22. Opelz G., and Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342 (1993) 1514-1516
23. Opelz G., and Döhler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 4 (2004) 222-230